The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Twelve hospitals across India will be part of the network which will support the trial in India
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
Subscribe To Our Newsletter & Stay Updated
